
Loading, please wait...

Loading, please wait...

Front of Pack Labelling (FOPL) remains a contested regulatory hurdle in India. Although the initial drafting process began in 2014, the Food Safety and Standards Authority of India (FSSAI) has yet to finalise these essential guidelines. In a recent Supreme Court affidavit, the regulator requested six additional weeks to submit a formal proposal. This delay occurs despite mounting evidence that high fat, sugar, and salt (HFSS) foods contribute significantly to non-communicable diseases (NCDs). Stakeholders remain divided on the best approach to inform consumers effectively.
India is currently facing a silent epidemic of lifestyle-related conditions. Data shows that NCDs account for nearly 60% of annual deaths in the country. Conditions like diabetes, hypertension, and obesity are rising rapidly among both adults and children. Since consumers often spend less than ten seconds choosing a product, clear labelling is vital. Consequently, medical experts argue that Front of Pack Labelling is an essential tool for public health intervention. Without it, patients often struggle to navigate the complexities of nutritional information panels.
The journey for FOPL has been exceptionally long and complex. FSSAI first drafted regulations in 2018 but later withdrew them for further deliberation. Between 2018 and 2026, multiple rounds of stakeholder meetings took place. In May 2025, the regulator held four regional consultations in major cities like Delhi and Kolkata. However, the food industry continues to raise serious concerns regarding the potential impact on traditional food sectors. Meanwhile, the Supreme Court has expressed dissatisfaction, noting that past exercises have yielded few positive results for the right to health.
A major point of contention involves the specific format of the labels. Industry associations generally favor a "Health Star Rating" system. This model gives an overall score but may mask high levels of specific unhealthy ingredients. On the other hand, consumer organisations and nutrition experts demand clear warning labels. Furthermore, these "high-in" symbols directly alert buyers to excessive salt, sugar, or fats. Therefore, medical professionals advocate for warning labels because they facilitate informed decisions at a glance. Recent studies suggest that warning labels are significantly more effective at helping Indian consumers identify unhealthy choices.
Q1: What is the primary purpose of Front of Pack Labelling?
FOPL aims to provide simplified, interpretive nutritional information on the front of food packages. It helps consumers quickly identify products high in fat, sugar, and salt (HFSS), which are linked to non-communicable diseases.
Q2: Why is the FSSAI delaying the implementation of FOPL?
The delay is primarily due to extensive consultations with stakeholders, including the food industry and consumer groups. Disagreements persist over whether to use a star-rating system or specific warning labels for unhealthy ingredients.
Q3: How does FOPL impact public health in India?
Effective FOPL can reduce the consumption of ultra-processed foods. By helping citizens make healthier choices, it directly addresses the rising incidence of obesity, diabetes, and cardiovascular diseases across the country.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


FSSAI's 8-year delay in implementing Front of Pack Labelling (FOPL) for HFSS foods faces Supreme Court scrutiny amid rising NCDs and obesity in India....
7 months ago

Following regulatory scrutiny from FSSAI regarding promotional representations and lean muscle preservation claims, Dr. Reddy's Laboratories and Nestlé Health Science are currently reviewing the branding and marketing strategy for their joint nutritional supplement Celevida GLP+.
Today

Demanding exhaustive hormonal profiling can inadvertently discourage clinical studies involving females. Methodological standards must align with the specific scientific question to expand, not restrict, equitable evidence for women.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

A novel calcium polyphosphate coacervate enables injectable bone implants with in situ hierarchical porosity via phase separation and gas foaming, significantly enhancing cell proliferation, energy metabolism, and osteogenic differentiation for minimally invasive bone defect repair.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today